Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
211.55
-0.51 (-0.24%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
75
76
Next >
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
September 18, 2023
Via
Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
September 15, 2023
Via
Benzinga
2 Dividend Kings to Buy on the Dip and Hold Forever
September 15, 2023
Don't ignore these stocks just because the rest of the market is.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via
Benzinga
Why Is Immuno-Oncology Firm Harpoon Therapeutics Stock Trading Lower Today?
September 14, 2023
Harpoon Therapeutics Inc (NASDAQ: HARP) shares are trading lower after AbbVie Inc (NYSE: ABBV) chose not to exercise its exclusive license option within the Development and Option Agreement...
Via
Benzinga
AbbVie Unusual Options Activity For September 13
September 13, 2023
Via
Benzinga
2 Undervalued Dividend Stocks to Buy Now
September 13, 2023
These two pharma titans are proven income vehicles.
Via
The Motley Fool
(ABBV) - Analyzing AbbVie's Short Interest
September 08, 2023
Via
Benzinga
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown
September 12, 2023
The market is set up for a fall, and it may start soon, as soon as the CPI data is released. These low-beta stocks are poised to outperform and pay dividends
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Economy
Interest Rates
US Equities
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
September 07, 2023
Data readout expected in Q4 2024
From
Alector, Inc.
Via
GlobeNewswire
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
August 31, 2023
Via
Benzinga
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
September 05, 2023
These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.
Via
InvestorPlace
The Truth About IPO Investing
September 02, 2023
When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Could CVS Make a Copy of Ozempic?
September 02, 2023
Given its new biosimilars unit, copying Ozempic is more likely than it sounds.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 02, 2023
Income investors should really like these biopharma stocks with juicy dividends.
Via
The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
CVS Just Made a Major New Announcement, But Should You Buy It?
September 01, 2023
Spinning up a new division will probably be a boon for shareholders.
Via
The Motley Fool
The 3 Most Promising Biotech Stocks to Own Now
August 31, 2023
These top biotech stock picks with high and leading growth potential are must-owns for investors looking for high upside potential.
Via
InvestorPlace
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
August 31, 2023
The healthcare giant's immunology drug Stelara brought in more than $9 billion in revenue last year.
Via
The Motley Fool
A Significant Reversal is in Sight for These 5 Med Tech Companies
August 30, 2023
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.
Via
MarketBeat
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity
August 29, 2023
If you're looking for a once-in-a-lifetime investment opportunity, consider these seven blue-chip stocks to buy now.
Via
InvestorPlace
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Nearing Retirement? These Stocks Will Pay You For Life
August 29, 2023
These companies are passive income machines.
Via
The Motley Fool
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
7 Stocks to Buy for the Rest of 2023
August 29, 2023
With the stock market off to a bombastic start, these top stocks for 2023 are worth betting on for the remainder of the year
Via
InvestorPlace
Late-Summer Steals: 7 Stocks to Buy Before Fall
August 28, 2023
With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.
Via
InvestorPlace
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
75
76
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.